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Available online 21 December 2011Abstract Insulin-like growth factor 1 (IGF-1) plays an important role in the regulation of tooth root development, and stem
cells from apical papilla (SCAPs) are responsible for the formation of root pulp and dentin. To date, it remains unclear whether
IGF-1 can regulate the function of SCAPs. In this study, SCAPs were isolated and purified from human immature root apex, and
stimulated by 100 ng/mL exogenous IGF-1. The effects of IGF-1 on the proliferation and differentiation of SCAPs were subse-
quently investigated. IGF-1 treated SCAPs presented the morphological and ultrastructural changes. Cell proliferation, alkaline
phosphatase (ALP) activity and mineralization capacity of SCAPs were increased by IGF-1. Western blot and quantitative RT-
PCR analyses further demonstrated that the expression of osteogenic-related proteins and genes (e.g., alkaline phosphatase,
runt-related transcription factor 2, osterix, and osteocalcin) was significantly up-regulated in IGF-1 treated SCAPs, whereas
the expression of odontoblast-specific markers (e.g., dentin sialoprotein and dentin sialophosphoprotein) was down-Abbreviations: ALP, alkaline phosphatase; α-MEM, alpha minimum essential medium; DSP, dentin sialoprotein; DSPP, dentin sialophosphopro-
tein; FBS, fetal bovine serum; FCM, flow cytometry; IGF-1, Insulin-like growth factor 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
OCN, osteocalcin; OSX, osterix; PVDF, polyvinylidene difluoride; RUNX2, runt-related transcription factor 2; SCAPs, stem cells from apical papilla
⁎ Correspondence to: Jinhua Yu, Institute of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing, Jiangsu 210029, China.
Fax: +86 25 85031861.
⁎⁎ Correspondence to: Guangdong Zhang, School of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing, Jiangsu 210029,
China. Fax: +86 25 85031861.
E-mail addresses: yuziyi_yjh@hotmail.com (J. Yu), egd_zhang@yahoo.com.cn (G. Zhang).
1 These authors contributed equally to this work and should be considered as co-first authors.
1873-5061/$ - see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.scr.2011.12.005
347regulated by IGF-1. In vivo results revealed that IGF-1 treated SCAPs mostly gave birth to bone-like tissues while untreated
SCAPs mainly generated dentin-pulp complex-like structures after transplantation. The present study revealed that IGF-1
can promote the osteogenic differentiation and osteogenesis capacity of SCAPs, but weaken their odontogenic differentiation
and dentinogenesis capability, indicating that IGF-1 treated SCAPs can be used as a potential candidate for bone tissue
engineering.
© 2011 Elsevier B.V. All rights reserved.Introduction
It is generally believed that root formation results from the in-
teractions between Hertwig's epithelial root sheath (HERS) and
adjacent undifferentiated mesenchymal cells. Stem cells from
the apical papilla (SCAPs) represent a population of early mes-
enchymal stem/progenitor cells residing in the root apex of im-
mature permanent teeth. These postnatal stem cells can
generate the calcium nodules in the osteo/odontogenic medi-
um and Oil red O-positive lipid clusters following the adipo-
genic induction in vitro(Sonoyama et al., 2006). Besides, they
can bring about the formation of bone-like tissues and dentin-
like tissues in vivo (Abe et al., 2008; Sonoyama et al., 2006;
Sonoyama et al., 2008). In physiological conditions, SCAPs con-
tribute to the formation of developing radicular pulp as well as
odontoblasts that are responsible for the root dentinogenesis,
and they also play a paramount role in the pulp healing and re-
generation (Huang et al., 2008; Sonoyama et al., 2008). Recent
clinical reports indicate that SCAPs are important to the apex-
ogenesis of developing roots and continuous root maturation in
teenagers suffering from the endodontic diseases (Banchs and
Trope, 2004; Chueh and Huang, 2006). Moreover, SCAPs have
been used as a competent candidate for dental tissue regener-
ation. Dentin-pulp-like tissues in the empty root canal space
and bioengineered roots which can support a porcelain crown
have been respectively generated by utilizing SCAPs recom-
bined with biological scaffolds in vivo (Huang et al., 2009;
Huang et al., 2010; Sonoyama et al., 2006).
During the tooth morphogenesis, growth factors and other
paracrine signal molecules mediate the interactions both be-
tween and within the epithelial and mesenchymal tissues,
such as the fibroblast growth factors (FGFs), transforming
growth factors (TGFs), bone morphogenetic proteins (BMPs),
and insulin-like growth factors (IGFs) (Caton and Tucker,
2009; Torres et al., 2006, 2008). FGF signaling pathways are
important to the evolution of mammalian dentition by giving
rise to new cusps and crests (Charles et al., 2009). Among
BMP family members, BMP2 has been extensively studied for
its biological functions during root development, and it can
promote dental pulp stem cell commitment to the odontoblast
lineage (Yang et al., 2009). IGF-1 and IGF-2 play an important
role in the regulation of tooth growth and differentiation.
Tooth explants treated with IGF-1 show an increase in both
dentin and enamel matrix, while IGF-2 appears to preferen-
tially affect the enamel deposition (Caton et al., 2005).
Following the odontoblastic differentiation, IGF-1 level is sig-
nificantly up-regulated (Liu et al., 2009). There is a statistically
significant difference of IGF-1 expression between immature
and mature dental pulps (Caviedes-Bucheli et al., 2004,
2007), and exogenous IGF-1 can elongate the molar roots
(Fujiwara et al., 2005). However, little knowledge is available
about its effect on the differentiation of SCAPs.In the present study, we hypothesize that IGF-1 plays an
important role in the proliferation and differentiation of
SCAPs. For this purpose, SCAPs were isolated from immature
human third molar apex and treated with exogenous IGF-1.
The effects of IGF-1 on SCAPs were subsequently evaluated
both in vitro and in vivo. Our experimental data showed
that the osteogenic differentiation and osteogenesis of
SCAPs were enhanced by IGF-1, while their odontogenic dif-
ferentiation and dentinogenesis were weakened, indicating
that these IGF-1 treated SCAPs can be used as a potential
candidate for bone tissue engineering.Results
IGF-1 modified the morphology and ultrastructure
of SCAPs
The effect of IGF-1 is mainly mediated through the type 1
IGF-1 receptor (IGF-1R). In this study, purified SCAPs
expressed IGF-1R gene (Fig. 1A) and protein (Fig. 1B).
These stem cells appeared microscopically as elongated
and spindle-shaped cells (Fig. 2A). After the treatment
with 100 ng/mL IGF-1 (Caton et al., 2005; Fujiwara et al.,
2005; Li et al., 2009), SCAPs became flat at day 7 and
many of them presented the typical osteoblast morphology,
i.e., cuboidal or polygonal shape with several cytoplasmic
processes (Fig. 2B). TEM analysis demonstrated that the
untreated cells possessed the typical ultrastructural fea-
tures of stem cells with a high nucleus/cytoplasm ratio and
poorly developed cytoplasmic organelles (Figs. 2C and E).
After the treatment with IGF-1, these stem cells contained
more organelles in the cytoplasm including the rough endo-
plasmic reticulum and mitochondria (Figs. 2D and F).IGF-1 promoted the proliferation of SCAPs
The cell-cycle analysis and MTT assay were performed to in-
vestigate whether IGF-1 can affect the proliferation of SCAPs
in vitro. Flow cytometry was used to investigate the prolifera-
tion index, i.e., the percentage of cells in S and G2M phases. As
shown in Figs. 3A and B, the proliferation index in the IGF-1
treated group at day 3 (S+G2M=29.97%) was significantly
higher than that in the untreated group (S+G2M=19.41%), in-
dicating that IGF-1 can promote the proliferation of SCAPs.
MTT assay revealed that the proliferation of IGF-1 treated
SCAPs were more active than that of untreated ones
(Fig. 3C). OD values significantly increased in the IGF-1 trea-
ted SCAPs compared with the untreated SCAPs from day 3 to
day 6 (Pb0.01). Moreover, SCAPs obtained from different do-
nors exhibited a similar upward trend of proliferation rate
when treated by IGF-1.
Figure 1 Expression of IGF-1R gene and protein in purified SCAPs. A: IGF-1R gene was detected in purified SCAPs by RT-PCR. β-
ACTIN was used as a loading control. B: SCAPs were positive for IGF-1R by immunocytochemistry. C: Negative control using PBS in-
stead of the primary antibody. Scale bars: B and C=100 μm.
348 S. Wang et al.IGF-1 enhanced osteogenic differentiation but
weakened odontogenic differentiation of SCAPs in
vitro
To further evaluate the differentiation ability, ALP activity
and matrix mineralization ability were analyzed at theFigure 2 Morphological changes of SCAPs treated by IGF-1. A: Unt
ted SCAPs became flat at day 7 and some of them were cuboidal or po
analysis showed that untreated SCAPs have the typical ultrastructura
immature cytoplasmic organelles. D and F: IGF-1 treated SCAPs con
doplasmic reticulum and mitochondria. Scale bars: A and B=50 μm; C
nucleus; P, cytoplasm; RER, rough endoplasmic reticulum.defined time points. ALP activity of SCAPs was increased by
IGF-1 at day 5 (Fig. 4A, Pb0.01). Moreover, SCAPs treated
with IGF-1 showed more mineralization nodules (Fig. 4B)
and higher calcium concentrations (Fig. 4C, Pb0.01) than
untreated group by alizarin red staining and CPC assay
after 14 days culure.reated SCAPs were elongated and spindle-shaped. B: IGF-1 trea-
lygonal containing multiple cytoplasmic processes. C and E: TEM
l features of stem cells, i.e., higher nucleus/cytoplasm ratio and
tained more organelles in the cytoplasm including the rough en-
and D=2 μm; E and F=1 μm. Abbreviations: M, mitochondria; N,
Figure 3 IGF-1 promoted the proliferation of SCAPs. A: Representative cell-cycle distribution profiles of untreated SCAPs. B: Rep-
resentative cell-cycle distribution profiles of IGF-1 treated SCAPs. C: Growth curves of untreated and treated SCAPs plotted from MTT
assay. The proliferation of IGF-1 treated SCAPs (days 3–6) was enhanced compared with untreated ones (**Pb0.01).
349Quantitative RT-PCR was performed to evaluate the ex-
pression levels of osteo/odontogenic genes including ALP,
RUNX2, OSX, OCN and DSPP. Compared with the untreated
group, there was a remarkable increase of the osteogenic
markers (i.e., ALP, RUNX2, OSX and OCN) at days 7 and 14 in
IGF-1 treated SCAPs,whereasDSPPmRNA levelwas significantly
decreased at day 14 in treated SCAPs (Fig. 5A). Western blot
analysis further verified these results. The protein expression
of RUNX2 (at days 3, 7 and 14), OSX (at day 14) and OCN (at
days 3, 7 and 14) in the IGF-1 treated group (Fig. 5B) was ele-
vated while DSP was down-regulated at day 14, in comparison
with the untreated group.IGF-1 increased osteogenesis ability of SCAPs in vivo
At 6 weeks, all implants were harvested and analyzed. By vi-
sual inspection, all retrieved implants shared similar colors,
sizes, and shapes. All implants exhibited mineralized tissues
protruding from the surface of renal capsules (Figs. 6A and
E). Radiographic analyses revealed that all implants con-
tained radioopaque tissues, in which the IGF-1 treated im-
plants presented more mineralized structures than the
control group (inlays in Figs. 6A and6E). Histologicalexamination indicated that untreated SCAPs mainly formed
(18/20) dentin-pulp-like structures involving predentin, ma-
ture dentin, odontoblast-like cells and dentinal tubules
(Figs. 6B and C) at week 6 post-transplantation. Polarized
light showed that untreated SCAPs produced collagen fibers
perpendicular to the matrix forming surface (Fig. 6D),
which is similar in structure to the primary dentin. However,
most IGF-1 treated SCAPs (14/20) generated the bone-like
tissues in which osteoblast-like cells were arranged regularly
along the surface of the calcified matrix and osteocyte-like
cells were embedded in the lacuna structures (Figs. 6F and
G). Collagen fibrils were deposited almost parallel to the
forming surface or poorly ordered like woven bone (Fig. 6H).
The expression of mineralization-related proteins (DSP,
OSX and OCN) was subsequently examined by immunohisto-
chemical staining. Retrieved untreated implants displayed
a positive expression of DSP (odontoblast marker; Fig. 7A)
in odontoblast-like cell layer, predentin, and dentin struc-
tures, while OSX expression (osteoblast marker; Fig. 7B)
was negative. However, OCN expression is positive in
odontoblast-like cells, weaker positive in osteodentin-like
tissues and negative in dentin (Fig. 7C). In IGF-1 treated
group, weaker expression of DSP (Fig. 7E), positive expres-
sion of OSX/OCN (bone specific proteins, Figs. 7F and G)
Figure 4 IGF-1 enhanced ALP activity and mineralization of SCAPs. A: Comparison of ALP activity between IGF-1 untreated and treated
SCAPs. There was no significant difference of ALP levels at day 3 between two groups. Treated group presented a higher ALP activity at day
5 than control group. B: Comparison of the mineralized nodules between IGF-1 untreated and treated SCAPs by alizarin red staining. IGF-1
treated SCAPs generated more calcified nodules than untreated group after 14-day culture. C: Calcium concentrations in treated SCAPs
were significantly higher than untreated ones (**Pb0.01).
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further confirmed that IGF-1 can promote the osteogenic dif-
ferentiation as well as the osteogenesis of SCAPs, but diminish
their odontogenic differentiation and dentinogenesis ability.Discussion
There is a growing evidence that IGFs play an important role
in the development of oro-dento-facial tissues and organs
(Caton et al., 2005; Werner and Katz, 2004; Yamamoto
et al., 2006), in which IGF-1 is involved in various processes
including tooth development, growth, periodontal ligament
homeostasis and different pathological circumstances
(Caton et al., 2005; Fujiwara et al., 2005; Kheralla et al.,
2010; Rath-Deschner et al., 2009). Diverse studies have
revealed that IGF-1 can affect the odontogenic differentia-
tion and dentin regeneration (Caton et al., 2007; Young,
1995). Moreover, IGF-1 can induce dental papilla cells to se-
crete the bone-like extracellular matrix (Caton et al., 2007).
Previous studies have proved that SCAPs have a potent ca-
pacity to differentiate along the odontoblast lineages and
perform the typical dentinogenesis (Abe et al., 2008; Lei
et al., 2011; Sonoyama et al., 2006; Sonoyama et al.,
2008). Therefore, it is reasonable that IGF-1 may have
some distinguishable effects on the differentiation of SCAPs.
In this study, exogenous IGF-1 can stimulate the prolifera-
tion and modify the ultrastructural morphology of SCAPs invitro. Besides, IGF-1 can up-regulate the ALP activity, the
mineralization capacity, and expression of several
osteoblast-related markers (ALP, RUNX2, OSX, OCN) in
SCAPs. As a characteristic marker of osteoblast phenotype,
ALP is an important marker during the early stage of osteogen-
ic differentiation (Hanai et al., 2006; Hong et al., 2010; Park
et al., 2009). The transcription factors RUNX2 and OSX are
also necessary for osteogenic differentiation (Baek et al.,
2009; Kaback et al., 2008; Komori, 2006). Disruption of
RUNX2 and OSX can result in a complete lack of bone forma-
tion and tooth germ abnormality (Kobayashi et al., 2006).
Moreover, RUNX2 can inhibit the terminal differentiation of
odontoblasts, induce the transdifferentiation of odontoblasts
into osteoblast lineages and form a bone structure (Miyazaki
et al., 2008). OCN is thought to play an important role in the
osteogenic differentiation and mineralization at the late
stages of bone formation. DSPP gene and DSP protein are the
putative differentiation markers of odontoblast lineages.
They are involved in the nucleation and control of the hy-
droxyapatite mineral phase during dentin calcification (Lee
et al., 2009; McKnight et al., 2008). Thus, the up-regulation
of osteoblast markers (i.e., RUNX2, OSX, OCN, and ALP) and
down-regulation of odontoblast markers (i.e., DSPP and DSP)
in IGF-1 treated group suggests that IGF-1 can enhance the os-
teogenic differentiation but weaken the odontogenic differen-
tiation of SCAPs. Moreover, the expression level of DSPP is
quite low in both treated and untreated SCAPs. The plausible
explanation for this phenomenon is that SCAPs from the
Figure 5 Effect of IGF-1 on osteo/odontogenic gene expression of SCAPs. A: QRT-PCR results of gene expression in untreated and trea-
ted samples for ALP, RUNX2, OSX, OCN and DSPP. GAPDHwas used as an internal control. Gene expression was described as a fold change
relative to the control group. Values are the means±SD n=4 (**2−ΔΔCt≥2, Pb0.01; *1b2−ΔΔCtb2, Pb0.01). B: Western blot results of pro-
tein levels in untreated and treated SCAPs for RUNX2, OSX, OCN and DSP. β-ACTIN was used as a loading control.
Figure 6 Histological evaluation of IGF-1 on SCAPs in vivo. A: Retrieved implants of untreated SCAPs after 6-week incubation in
vivo observed by visual inspection and radiographic analyses. B and C: Histological examination of the retrieved implants of untreated
SCAPs. Odontoblast-like cell, predentin, and dentin tissues appeared in the mineralized structures. D: Polarized light demonstrated
the perpendicular alignment of collagen fibers to the dentin surface in untreated implants. E: Retrieved implants of IGF-1 treated
SCAPs after 6-week incubation in vivo observed by visual inspection and radiographic analyses. F and G: Histological examination
of the retrieved implants of IGF-1 treated SCAPs. Bone-like tissues were generated. Osteocytes within the osseous lacunae and
osteoblast-like cells on the bone-forming surface can be observed in the mineralized tissue. H: Collagen fibrils under the polarized
light were deposited almost parallel to the forming surface or poorly ordered like woven bone in IGF-1 treated implants. Scale bar:
A and E=1 cm. B, C, D, F, G and H=50 μm. Abbreviations: B, bone-like tissue; CF, collagen fibers; D, dentin; OBC, osteoblast-like cell;
OC, osteocyte-like cell; ODB, odontoblast-like cell; PD, predentin.
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Figure 7 Immunohistological staining of osteo/odontogenic markers in IGF-1 treated SCAPs in vivo. A: Immunohistological positive
staining for DSP in odontoblast-like cells, predentin, and dentin structures of untreated SCAPs pellets. B: Negative staining for OSX in
odontoblastic layer and dentin of untreated SCAPs pellets. C: Positive staining for OCN in odontoblast-like cells and weaker positive in
osteodentin-like tissues of untreated SCAPs pellets. Negative staining for OCN appeared in dentin layer. D: Negative control using PBS
instead of primary antibodies in untreated SCAPs pellets. E: Weaker positive staining for DSP in bone-like structures generated by IGF-
1 treated SCAPs. F: Positive staining for OSX in osteoblast-like cells of IGF-1 treated SCAPs pellets. G: Positive staining for OCN in
bone-like structures generated by IGF-1 treated SCAPs. H: Negative control using PBS instead of primary antibodies in IGF-1 treated
SCAPs implants. Scale bars=50 μm. Abbreviations: B, bone-like tissue; D, dentin; OD, osteodentin-like tissues; ODB, odontoblast-like
cell; PD, predentin.
352 S. Wang et al.developing dental tissues are more primitive and they cannot
achieve full odontoblastic differentiation under in vitro cul-
ture conditions due to the loss of suitable microenvironment
(Sonoyama et al., 2008).
Some studies have demonstrated that RUNX2 and OSX are
important for osteogenic and odontogenic differentiation, and
both can regulate the expression of other osteo/odontogenic
genes. In this paper, although RUNX2 and OSX were both highly
expressed in IGF-1 treated SCAPs, these stem cells mainly dif-
ferentiate along the osteoblast lineages instead of odontoblast
lineages both in vitro and in vivo, suggesting that RUNX2 and
OSX may act on different downstream target genes and affect
different signaling pathways when SCAPs differentiate along
different cell lineages, i.e., osteoblasts and odontoblasts
(Chen et al., 2009; Chen et al., 2005; James et al., 2006).
The results of transplantation in vivo further confirmed
this conclusion. Untreated SCAPs mainly generated dentin-
pulp-like tissues, whereas IGF-1 treated SCAPs mostly
brought about the formation of bone-like structures, indi-
cating that IGF-1 can enhance the osteogenic potential but
weaken their odontogenic capacity of SCAPs in vivo. Bone
and dentin are mineralized tissues that closely resemble
each other in composition and mechanism of formation.
They are both formed by matrix-mediated mineralization
mechanisms in which type I collagen generates the structur-
al template for the epitaxial nucleation of hydroxyapatite.
The specific mechanisms involved in controlling bone and
dentin formation are still unknown. Non-collagenous pro-
teins are generally believed to actively regulate the hy-
droxyapatite crystal nucleation, growth shape and
orientation during the osteogenesis and dentinogenesis
(Butler et al., 2002; Qin et al., 2004). These non-
collagenous proteins are similar in odontoblasts and osteo-
blasts, and no definite protein is found specific. However, theexpression of these molecules has the quantity differences be-
tween the two processes which induce the different final struc-
tures, i.e., bone and predentin. Our findings revealed that IGF-
1 changed the collagen alignment and expression pattern of
non-collagenous proteins, including the up-regulation of
RUNX2/OSX/OCN and down-regulation of DSP. This maymodify
the cell polarization and mineralization pattern of IGF-1 trea-
ted SCAPs in vivo, which ultimately brings about the formation
of bone-like tissues.
The effects of IGF-1 on bone formation have been exten-
sively investigated, and many studies have demonstrated
that IGF-1 is one of the key regulators of osteoblast differen-
tiation/proliferation and exerts a beneficial effect on bone
development/homeostasis (He et al., 2006; Kanbur et al.,
2005; Tiago et al., 2010; Yao et al., 2008). IGF-1 triggers at
least two signaling pathways, i.e., Ras/Raf-1/MAPK pathway
and PI3K/PDK-1/Akt pathway (Grey et al., 2003;
Hatakeyama et al., 2008; Laviola et al., 2007; Wu et al.,
2008). The activation of PI3K/PDK-1/Akt pathway contrib-
utes to the osteoblast survival as well as cellular prolifera-
tion and differentiation. It is noted that p42/44 MAPK in
Ras/Raf-1/MAPK pathway can converge with PI3K/PDK-1/
Akt pathway on the downstream effector. IGF-1 can stimu-
late ALP activity via MAPK and PI3K pathways (Hanai et al.,
2006; Noda et al., 2005), and regulate the activity of
RUNX2 and OSX via Akt-independent pathway and MAPK
pathways (Celil and Campbell, 2005; Qiao et al., 2004). Fur-
thermore, IGF-1 signals may modulate osteoblast mitogen-
esis and survival through parallel PI3K and MAPK pathways
(Grey et al., 2003). Meanwhile, IGF-1 may favor the osteo-
blastogenesis by regulating β-catenin, a signaling molecule
used by Wnt canonical signaling pathway, which is essential
for the osteogenesis (Canalis, 2009; Krishnan et al., 2006;
Wang et al., 2010). Since IGF-1 treated SCAPs mainly
353differentiated along the osteoblast lineages and generated
bone-like tissues, it is plausible that IGF-1 may regulate
SCAPs in a way similar to the regulation of osteogenic
differentiation.Conclusion
The in vitro and in vivo evidence accumulated in the present
study revealed for the first time that IGF-1 can promote the
osteogenic differentiation and osteogenesis, but decrease
the odontogenic differentiation and dentinogenesis capacity
of SCAPs, suggesting that IGF-1 treated SCAPs can be used as
a potential candidate for bone tissue engineering. Further
studies are required to explore the potential signaling path-
ways regulating the osteogenic differentiation of IGF-1 trea-
ted SCAPs.Materials and methods
Cell isolation and culture
Impacted third molars (n=24) were collected from young pa-
tients (17–20 years old) in Oral Surgery Department of Jiangsu
Provincial Stomatological Hospital after the informed consent
was obtained. The apical papillae were gently detached from
the immature roots, minced and digested in a solution con-
taining 3 mg/mL collagenase type I (Sigma, St. Louis, MO)
and 4 mg/mL dispase (Sigma, St. Louis, MO) for 30 min at
37 °C. Then, these cells were purified by using rabbit anti-
STRO-1 antibody (Santa Cruz, Delaware, CA) and sheep anti-
rabbit IgG Dynabeads (Dynal Biotech, Oslo, Norway) according
to the standard procedures for magnetic activated cell sorting
(MACS). Purified stem cells from apical papilla (SCAPs) were
seeded at 1×104 cells/mL into 10 cm culture dishes and cul-
tured in alpha minimum essential medium (α-MEM, Gibco,
Life Technologies, Grand Island, NY) supplemented with 10%
fetal bovine serum (Hyclone, USA), 100 U/mL penicillin and
100 μg/mL streptomycin at 37 °C in 5% CO2. The freshmedium
was changed every 2 days. Cells were subcultured at the ratio
of 1:3 when they reached 75~85% confluence. SCAPs at 1–3
passages were used for subsequent experiments. The expres-
sion of IGF-1R gene and protein in purified SCAPs was respec-
tively detected by RT-PCR and immunocytochemistry
methods (IGF-1R antibody was purchased from Bioworld Tech-
nology, USA). The treated cells were cultured in α-MEM con-
taining 100 ng/mL IGF-1 (Peprotech, USA). Stem cells were
routinely examined under the phase-contrast inverted micro-
scope (Olympus). STRO-1+ SCAPs were isolated from the
same donor in some experiments, and SCAPs at the same pas-
sage were used in each experiment.Cell morphology and ultrastructure
Morphological changes of IGF-1 untreated and treated SCAPs
were evaluated at day 7 by a computer-control digit imaging
system (Olympus, Japan). Meanwhile, 1×107 cells at day 7
were collected by centrifugation to deposit the cell pellets
for ultrastructural analysis. The pellets were fixed in a 2.5%
glutaraldehyde solution at 4 °C overnight, and then examinedby transmission electron microscopy (TEM) (JEM-2000EX,
Japan).
MTT assay for cell growth curve
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2,5-tetrazolium
bromide) assay was performed to investigate the cell metabolic
activity. Briefly, SCAPs were seeded into 96-well plates (Costar)
at a density of 5×103 cells/well, and divided into IGF-1
untreated and treated groups. After 1, 2, 3, 4, 5, and 6 days
of culture, 20 μL fresh MTT solution (5 mg/mL; Sigma-
Aldrich, St. Louis, MO, USA) was added into the wells and incu-
bated for 4 h at 37 °C. MTT-formazan crystals were then solu-
bilized with dimethyl sulfoxide (DMSO), and the absorbance
was measured at 490 nm using a microtiter plate reader
(Titertek, Helsinki, Finland). Five independent experiments
were performed in each group, and the graph was plotted
according to the average value.
Flow cytometry for cell cycle
After 3-day culture, IGF-1 untreated and treated SCAPs
(1×106) were respectively collected by exposure to trypsin/
EDTA for 5 min and centrifuged at 1100 rpm for 3 min. Cell
precipitates were washed twice with 0.01 mol/L PBS and
resuspended in 1 mL physiologic saline, fixed in 2 mL cold
dehydrated alcohol, and stored at 4 °C overnight. Then,
each sample was washed again with PBS, and incubated with
propidium iodide (100 mg/mL; Sigma) on ice for at least
30 min. Cell cycle fractions (G0G1-, S-, G2M-phases) were
then determined by flow cytometry. Three independent ex-
periments from different donors were performed for each
group.
Alkaline phosphatase (ALP) assay and alizarin red
staining
SCAPs were grown in the α-MEM containing 100 ng/mL IGF-1.
At days 3 and 5, ALP activity of IGF-1 untreated and treated
SCAPs was performed as described previously (Fan et al.,
2009; Lei et al., 2011) with an ALP kit (Sigma-Aldrich) and
normalized on the basis of equivalent protein concentra-
tions. At day 14, alizarin red staining was carried out and im-
ages were acquired using a scanner. Then, alizarin red was
destained with 10% cetylpyridinium chloride (CPC) in
10 mmol/L sodium phosphate for 30 min at room tempera-
ture. The calcium concentrations were determined according
to the absorbance at 562 nm using a standard calcium curve
prepared in the same solution. The final calcium levels in
each group were normalized with the total protein concentra-
tions obtained from the duplicate plates.
Real-time RT-PCR
Total cellular RNA was obtained by adding TRIzol reagent
(Invitrogen, Carlsbad, CA) to cell samples. Isolated RNA pre-
cipitates were completely dissolved in diethypyrocarbonate
(DEPC) treated water (Ambion Inc., Austin, USA) and re-
versely transcribed using SuperScript® III cDNA Synthesis
Kit (Invitrogen). Real-time RT-PCR was performed using
354 S. Wang et al.SYBR® Premix Ex Taq™ kit (TaKaRa, Bio, Otsu, Japan) and
ABI 7300 real-time PCR system. Primer sets used for the de-
tection of ALP, RUNX2, OSX, OCN, DSPP and GAPDH were
listed in Table 1. Real-time RT-PCR reaction conditions
were: 95 °C for 30 s; followed by 40 cycles of 95 °C for 5 s
60 °C for 31 s. The results were calculated from three inde-
pendent experiments.
Western blot analysis
IGF-1 untreated and treated SCAPs were respectively col-
lected after 3-day, 7-day and 14-day culture, washed twice
with cold PBS and lysed in RIPA lysis buffer (Beyotime,
China) containing 1 mM phenylmethylsulfonyl fluoride
(PMSF). Cell debris was eliminated by centrifugation at
12,000 rpm for 10 min. Protein concentrations were deter-
mined via Bio-Rad protein assay kit (Pierce, Rockford, IL).
30 μg proteins per lane were loaded on a SDS-PAGE gel for
electrophoresis, and then transferred onto PVDF membranes
(Millipore Co. Bedford, MA, USA) at 300 mA for 1 hour in a
blotting apparatus (Bio-RAD, CA, USA). Membranes were
blocked at room temperature for 2 h with blocking solution
(5% w/v skim milk, 0.01 mol/L PBS, 0.1% Tween-20), and
subsequently incubated overnight at 4 °C with primary poly-
clonal antibodies against RUNX2 (1:300; BOSTER, China), DSP
(1:500; Santa Cruz), OSX (1:300; BOSTER, China), OCN
(1:300; BOSTER, China) and monoclonal antibody against β-
ACTIN (1:1,000; ABGENT, Flanders Count, CA, USA). Then,
the membranes were rinsed with PBST (0.1% Tween-20 in
0.01 mol/L PBS), incubated with appropriate horseradish per-
oxidase conjugated secondary antibodies at 1:5000 (Santa
Cruz) at room temperature for additional 1 h, visualized by
SuperSignal West Pico Chemiluminescent Substrate (Thermo,
Rockford, USA) and exposed to Kodak X-ray films. β-ACTIN
served as an internal control in these experiments.
In vivo transplantation
All animal experiments were conducted in accordance with
accepted standards of humane animal care and approvedTable 1 Forward and reverse primers for reverse transcription-p
Gene GenBank No. Sequ
ALP NM_000478.4 Forw
Reve
RUNX2 NM_001024630.3 Forw
Reve
OSX NM_001173467.1 Forw
Reve
OCN NM_001199662.1 Forw
Reve
DSPP NM_014208.3 Forw
Reve
GAPDH NM_002046.3 Forw
Reve
IGF-1R NM_000875.3 Forw
Reve
β-ACTIN NM_001101.3 Forw
Reveby Animal Care Committee of Nanjing Medical University
(reference no. 200900128). 1×106 IGF-1 treated SCAPs at
day 7 were collected by exposure to trypsin/EDTA for 5 mi-
nutes, spun down as cell pellets, maintained in α-MEM sup-
plemented with 10% FBS, and incubated for another 3 h in
tubes to make them well aggregated. IGF-1 treated cell pel-
lets were seeded onto the AGS (absorbable gelatin sponges;
Nanjing Pharmaceuticals) pre-immersed with 100 ng/mL
IGF-1 solution and then transplanted into the renal capsules
of immunocompromised mice. Untreated cell pellets on AGS
materials served as a control. In the present study, AGS was
used as a carrier which can facilitate the transfer of cell pel-
lets from tubes to the renal capsules. All pellets (20 in IGF-1
treated group and 20 in untreated group) were retrieved at
week 6 post-transplantation and radiographic analyses
were performed by using FOCUS X-ray machine (Cone
50540, Tuusula, Finland) with Sopix-2 CCD sensors at 50 Kv
and 7 mA for 0.63 s at a focal distance of 20 cm. After visual
and radiographic inspections, these implants were fixed in
4% polyoxymethylene, decalcified, and processed for hema-
toxylin and eosin staining (H&E) and polarized light
observation.Immunohistochemistry
Immunocytochemical analyses of recovered implants were
performed using the streptavidin-biotin complex method
according to the manufacturer's recommended protocol.
Briefly, tissue sections (5 μm) from representative paraffin
blocks were deparaffinized in xylene and rehydrated through
graded ethanol solutions. Endogenous peroxidases were
blocked using 3% hydrogen peroxide. For the antigen retrieval,
the sections were processed by the conventional microwave
heating in 0.01 M sodium citrate retrieval buffer (0.01 M sodi-
um citrate and 0.01 M citric acid, pH 6.0) for 5 min. Then, the
sections were blocked by 10% normal swine serum for 20 min
and incubated with primary antibodies (DSP, 1:200; OSX,
1:100; OCN, 1:00) overnight at 4 °C. Incubation with PBS in-
stead of primary antibodies served as the negative controls.
Finally, the sections were incubated with secondaryolymerase chain reaction.
ences ( 5′–3′) Size (bp)
ard: GACCTCCTCGGAAGACACTC 137
rse: TGAAGGGCTTCTTGTCTGTG
ard: TCTTAGAACAAATTCTGCCCTTT 136
rse: TGCTTTGGTCTTGAAATCACA
ard: CCTCCTCAGCTCACCTTCTC 148
rse: GTTGGGAGCCCAAATAGAAA
ard: AGCAAAGGTGCAGCCTTTGT 63
rse: GCGCCTGGGTCTCTTCACT
ard: ATATTGAGGGCTGGAATGGGGA 136
rse: TTTGTGGCTCCAGCATTGTCA
ard: GAAGGTGAAGGTCGGAGTC 225
rse: GAGATGGTGATGGGATTTC
ard: GCGCCTCCAACTTCGTCT 423
rse: CGTACAGCATAATCACCAACCC
ard: CTCCATCCTGGCCTCGCTGT 268
rse: GCTGTCACCTTCACCGTTCC
355antibodies for 45 min at room temperature. The reaction
products were developed by 3, 3′-diaminobenzidine solution
with hydrogen peroxide and counterstainedwith hematoxylin.
Statistics
The quantitative results were expressed as mean±SD. Indepen-
dent samples t-test and Chi-square test were performed with
SPSS-Windows v.12.0 software. P-values less than 0.05 were
considered to be statistically significant.
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